Harvard's David M. Nathan, M.D., to speak as Visiting Professor April 18
As part of the Taubman Institute's visiting professor program, eminent endocrinologist David M. Nathan, M.D., of Harvard University will deliver two lectures at the University of Michigan Health System on April 18.
Dr. Nathan, an internationally recognized expert on diabetes and its complications, will first address Internal Medicine Grand Rounds at noon in Ford Auditorium. His presentation is titled, “The Type 2 Diabetes Epidemic: Prevention and Therapy.”
Later the same afternoon at 2 p.m., Dr. Nathan will present “Diabetes Trials and Tribulations in 2014: What do we know?” at the Division of Metabolism, Endocrinology & Diabetes (MEND) Combined Clinical/Research Conference and Diabetes Grand Rounds.
The Taubman Institute regularly collaborates with other University of Michigan Medical School departments to invite distinguished thought leaders in medical research to speak on the U-M campus in Ann Arbor. The lectures are generally held monthly and represent the Taubman Institute's ongoing commitment to furthering translational medical research by creating opportunities for the most talented physician-researchers to exchange knowledge and ideas.
Taubman-sponsored research offers breast tumor insights
Taubman Emerging Scholar Dr. Scott Tomlins has authored a new study about phyllodes tumors.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
Familial ALS affects generations
Detroit News column featuring Dr. Eva Feldman depicts the toll of the disease on one Metro Detroit family
news & events
In the News
PBS series features institute director on Jan. 18
"The Embrace of Aging," a documentary series airing Sundays at 2:30 p.m. on Detroit Public Televsion, features Taubman Institute Director Eva Feldman, M.D., Ph.D. and her landmark ALS stem cell trial in the Jan. 18 episode.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.